Effects of heparin on temporal microRNA profiles.
作者信息
Mayr Manuel, Lee Regent, Kaudewitz Dorothee, Zampetaki Anna, Channon Keith M
出版信息
J Am Coll Cardiol. 2014 Mar 11;63(9):940-1. doi: 10.1016/j.jacc.2013.07.118. Epub 2013 Dec 4.
Abstract
摘要
相似文献
1
Effects of heparin on temporal microRNA profiles.肝素对颞部微小RNA谱的影响。
J Am Coll Cardiol. 2014 Mar 11;63(9):940-1. doi: 10.1016/j.jacc.2013.07.118. Epub 2013 Dec 4.
2
Reply: effects of heparin on temporal microRNA profiles.
J Am Coll Cardiol. 2014 Mar 11;63(9):941-2. doi: 10.1016/j.jacc.2013.09.077. Epub 2013 Dec 4.
3
MicroRNA and myocardial infarction: a mystery turning into glory?微小RNA与心肌梗死：谜团正在转化为荣耀？
J Am Coll Cardiol. 2013 Sep 10;62(11):999-1001. doi: 10.1016/j.jacc.2013.03.084. Epub 2013 Jun 7.
4
Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy.经冠状静脉消融治疗室间隔肥厚患者的循环肌丰富 microRNAs 的释放动力学。
J Am Coll Cardiol. 2013 Sep 10;62(11):992-8. doi: 10.1016/j.jacc.2013.05.025. Epub 2013 Jun 7.
5
When do we monitor for the effects of a "therapeutic" myocardial infarction?
Prog Cardiovasc Nurs. 2002 Summer;17(3):152-4. doi: 10.1111/j.0889-7204.2002.01539.x.
6
Acute myocardial infarction occurring after hypertrophic obstructive cardiomyopathy with paroxysmal atrial fibrillation: a case report.肥厚型梗阻性心肌病伴阵发性心房颤动后发生的急性心肌梗死：1 例报告。
J Int Med Res. 2022 Oct;50(10):3000605221133702. doi: 10.1177/03000605221133702.
7
Disappearance of septal Q waves following percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy.
Am J Cardiol. 2003 Feb 15;91(4):515-6. doi: 10.1016/s0002-9149(02)03293-9.
8
Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者的血浆和心肌微小RNA谱
Clin Transl Med. 2021 Jul;11(7):e435. doi: 10.1002/ctm2.435.
9
In percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the amount of alcohol injected that determines the resultant infarct size.在经皮腔内间隔心肌消融治疗肥厚性梗阻性心肌病时，决定最终梗死面积的不是冠状动脉内酒精注射的速度，而是注射的酒精量。
Circulation. 2004 Jul 20;110(3):e23; author reply e23. doi: 10.1161/01.CIR.0000135537.69990.0F.
10
Septal myectomy for hypertrophic obstructive cardiomyopathy: coil, boil and the role of rescue surgery.
Eur J Cardiothorac Surg. 2009 Jul;36(1):210-1. doi: 10.1016/j.ejcts.2009.03.033. Epub 2009 May 1.
引用本文的文献
1
Peripheral blood RNA biomarkers for cardiovascular disease from bench to bedside: a position paper from the EU-CardioRNA COST action CA17129.从实验室到临床：心血管疾病外周血 RNA 生物标志物——EU-CardioRNA COST 行动 CA17129 的立场文件。
Cardiovasc Res. 2022 Dec 29;118(16):3183-3197. doi: 10.1093/cvr/cvab327.
2
A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy.循环 microRNAs 作为心血管疾病生物标志物成功应用的关键方法：以肥厚型心肌病为例。
Heart Fail Rev. 2022 Jan;27(1):281-294. doi: 10.1007/s10741-021-10084-y. Epub 2021 Mar 3.
3
MiR-223 levels predicting perioperative bleeding in off-pump coronary artery bypass grafting.微小RNA-223水平预测非体外循环冠状动脉旁路移植术围手术期出血情况
Ann Transl Med. 2020 Nov;8(21):1341. doi: 10.21037/atm-20-2022b.
4
Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury.循环非编码 RNA 与蛋白生物标志物在心肌损伤检测中的比较分析。
Circ Res. 2019 Jul 19;125(3):328-340. doi: 10.1161/CIRCRESAHA.119.314937. Epub 2019 Jun 4.
5
Optimisation of laboratory methods for whole transcriptomic RNA analyses in human left ventricular biopsies and blood samples of clinical relevance.优化人类左心室活检和临床相关血液样本的全转录组 RNA 分析的实验室方法。
PLoS One. 2019 Mar 14;14(3):e0213685. doi: 10.1371/journal.pone.0213685. eCollection 2019.
6
Optimized Collection Protocol for Plasma MicroRNA Measurement in Patients with Cardiovascular Disease.心血管疾病患者血浆微小RNA检测的优化采集方案
Biomed Res Int. 2016;2016:2901938. doi: 10.1155/2016/2901938. Epub 2016 Sep 20.
7
Heparinase treatment of heparin-contaminated plasma from coronary artery bypass grafting patients enables reliable quantification of microRNAs.用肝素酶处理冠状动脉搭桥手术患者受肝素污染的血浆，可实现对微小RNA的可靠定量。
Biomol Detect Quantif. 2016 Apr 8;8:9-14. doi: 10.1016/j.bdq.2016.03.001. eCollection 2016 Jun.
8
MicroRNA Biomarkers for Coronary Artery Disease?用于冠状动脉疾病的微小RNA生物标志物？
Curr Atheroscler Rep. 2015 Dec;17(12):70. doi: 10.1007/s11883-015-0548-z.
9
MicroRNAs as clinical biomarkers?微小RNA作为临床生物标志物？
Front Genet. 2015 Jul 14;6:240. doi: 10.3389/fgene.2015.00240. eCollection 2015.
10
Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device.用于预测和监测左心室辅助装置机械循环支持反应的循环微RNA
Eur J Heart Fail. 2014 Aug;16(8):871-9. doi: 10.1002/ejhf.116. Epub 2014 Jun 24.
本文引用的文献
1
Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease.静脉肝素对冠心病患者循环 microRNAs 定量检测的影响。
Thromb Haemost. 2013 Sep;110(3):609-15. doi: 10.1160/TH13-05-0368. Epub 2013 Jun 27.
2
Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy.经冠状静脉消融治疗室间隔肥厚患者的循环肌丰富 microRNAs 的释放动力学。
J Am Coll Cardiol. 2013 Sep 10;62(11):992-8. doi: 10.1016/j.jacc.2013.05.025. Epub 2013 Jun 7.
3
MicroRNA and myocardial infarction: a mystery turning into glory?微小RNA与心肌梗死：谜团正在转化为荣耀？
J Am Coll Cardiol. 2013 Sep 10;62(11):999-1001. doi: 10.1016/j.jacc.2013.03.084. Epub 2013 Jun 7.
4
Heparin selectively affects the quantification of microRNAs in human blood samples.肝素选择性地影响人体血液样本中微小RNA的定量分析。
Clin Chem. 2013 Jul;59(7):1125-7. doi: 10.1373/clinchem.2012.199505. Epub 2013 Apr 23.
5
Circulating microRNAs as novel biomarkers for platelet activation.循环 microRNAs 作为血小板活化的新型生物标志物。
Circ Res. 2013 Feb 15;112(4):595-600. doi: 10.1161/CIRCRESAHA.111.300539. Epub 2013 Jan 2.
6
Prospective study on circulating MicroRNAs and risk of myocardial infarction.前瞻性研究循环 MicroRNAs 与心肌梗死风险。
J Am Coll Cardiol. 2012 Jul 24;60(4):290-9. doi: 10.1016/j.jacc.2012.03.056.
7
Analytical challenges and technical limitations in assessing circulating miRNAs.评估循环 miRNA 时的分析挑战和技术限制。
Thromb Haemost. 2012 Oct;108(4):592-8. doi: 10.1160/TH12-02-0097. Epub 2012 May 25.
8
Controversies in cardiovascular medicine. Hypertrophic obstructive cardiomyopathy: alcohol septal ablation.心血管医学争议。肥厚型梗阻性心肌病：酒精室间隔消融术。
Eur Heart J. 2011 May;32(9):1059-64. doi: 10.1093/eurheartj/ehr013. Epub 2011 Mar 29.
Zotero 插件